Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TAmiRNA
Vienna, Vienna, Austriatamirna.com ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
01
Overview
TAmiRNA is a biotech company specializing in the discovery and development of microRNA (miRNA) biomarkers for diagnostic and therapeutic applications. The company leverages its proprietary platform to identify miRNA signatures associated with aging-related diseases, including osteoporosis, cardiovascular disorders, and liver disease. TAmiRNA offers a range of diagnostic kits, such as osteomiR for bone health and hepatomiR for liver function, while also advancing a pipeline of miRNA-based therapeutic candidates. By integrating advanced transcriptomics with clinical data, the company aims to provide personalized medicine solutions that improve patient outcomes through early detection and targeted treatment.
- Therapeutic areas
- CardiovascularMetabolic DisordersEndocrinologyGastroenterologyOncology
- Modalities
- RNA therapyAntisense oligonucleotideDevice
- Industry
- Biotech
02
Partnerships
EurofinsMedical University of ViennaUniversity of Natural Resources and Life Sciences (BOKU)
Beyond the preview
Go deeper on TAmiRNA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TAmiRNA.